Amicus Therapeutics (NASDAQ: FOLD) withdraws common stock listing

Rhea-AI Filing Summary

Amicus Therapeutics, Inc. notified Nasdaq of the removal of its Common Stock from listing and registration on the Nasdaq Stock Market. The filing states the Exchange "struck the class of securities from listing" and that the issuer complied with rules "governing the voluntary withdrawal".

Key Figures

Commission File Number: 001-33497 Form expiration date: March 31, 2018 Issuer telephone: +1 609 662-2000

3 metrics

Commission File Number 001-33497 Form 25 cover data

Form expiration date March 31, 2018 form header expiry

Issuer telephone +1 609 662-2000 Issuer principal executive offices

Key Terms

Form 25, struck the class of securities from listing, voluntary withdrawal

3 terms

Form 25 regulatory

"FORM 25 NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION"

A Form 25 is an official filing with the U.S. Securities and Exchange Commission used to remove a company's stock or other security from a national exchange list. Investors should care because delisting often means less visibility, lower trading volume and wider price swings—similar to a product moving from a major supermarket to a small local market, which can make buying, selling and valuing the security more difficult.

struck the class of securities from listing regulatory

"the Exchange has complied with its rules to strike the class of securities from listing"

voluntary withdrawal regulatory

"the Issuer has complied with its rules of the Exchange and the requirements ... governing the voluntary withdrawal"

UNITED STATES

OMB APPROVAL

OMB Number:			3235-0080
Expires:	March 31, 2018
Estimated average burden
hours per response:			1.7

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 25

NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION
UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934.

Commission File Number

001-33497

Issuer:	AMICUS THERAPEUTICS, INC.
Exchange:	Nasdaq Stock Market LLC

(Exact name of Issuer as specified in its charter, and name of Exchange where security is listed and/or registered)

Address:	1 Cedar Brook Drive
	Cranbury	NEW JERSEY	08512
Telephone number:					+1 609 662-2000

(Address, including zip code, and telephone number, including area code, of Issuer's principal executive offices)

Common Stock

(Description of class of securities)

Please place an X in the box to designate the rule provision relied upon to strike the class of securities from listing and registration:

17 CFR 240.12d2-2(a)(1)

17 CFR 240.12d2-2(a)(2)

17 CFR 240.12d2-2(a)(3)

17 CFR 240.12d2-2(a)(4)

Pursuant to 17 CFR 240.12d2-2(b), the Exchange has complied with its rules to strike the class of securities from listing and/or withdraw registration on the Exchange. ¹

Pursuant to 17 CFR 240.12d2-2(c), the Issuer has complied with its rules of the Exchange and the requirements of 17 CFR 240.12d-2(c) governing the voluntary withdrawal of the class of securities from listing and registration on the Exchange.

Pursuant to the requirements fo the Securities Exchange Act of 1934, Nasdaq Stock Market LLC certifies that it has reasonable grounds to believe that it meets all of the requirements for filing the Form 25 and has caused this notification to be signed on its behalf by the undersigned duly authorized person.

2026-04-27	By	Tara Petta		AVP
Date		Name		Title

¹ Form 25 and attached Notice will be considered compliance with the provisions of 17 CFR 240.19d-1 as applicable. See General Instructions.

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

Why did Amicus Therapeutics (FOLD) file Form 25?

Answer: The filing notifies Nasdaq that the class of Common Stock has been removed from listing and registration. The form states the Exchange struck the securities and that the issuer complied with rules "governing the voluntary withdrawal" of the class of securities.

Does the Form 25 state the method of removal for FOLD common stock?

Answer: Yes. The Form 25 states Nasdaq "struck the class of securities from listing" and references compliance with rules for a "voluntary withdrawal" by the issuer, indicating the removal was processed under the Exchange's and issuer's withdrawal procedures.

Who signed the Form 25 for the Nasdaq action involving FOLD?

Answer: The notification was signed on behalf of Nasdaq Stock Market LLC by an authorized representative named Tara Petta, identified as AVP, certifying the Exchange had reasonable grounds to file the Form 25 under the Exchange Act.

What class of Amicus Therapeutics securities is affected by the filing?

Answer: The Form 25 specifically references the company's Common Stock as the class of securities removed from listing and registration on the Nasdaq Stock Market, per the language in the notification.